Ligand validation:5TL9

GSH: GLUTATHIONE

GSH is a Ligand Of Interest in 5TL9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5TL9_GSH_A_202	98%	57%	0.066	0.988	0.7	0.96	-	1	0	0	100%	1
5K0I_GSH_A_202	97%	20%	0.073	0.988	2.23	1.22	2	2	0	0	100%	1
5T36_GSH_A_202	97%	12%	0.077	0.99	3.02	1.07	2	3	0	0	100%	1
5T37_GSH_A_202	94%	12%	0.075	0.976	3.02	1.07	2	3	0	0	100%	1
5BQI_GSH_A_202	93%	58%	0.089	0.983	0.71	0.91	-	2	0	0	100%	1
4BPM_GSH_A_1172	76%	55%	0.119	0.956	0.53	1.18	-	1	0	0	100%	1
3R2Q_GSH_A_301	100%	42%	0.036	0.992	1.11	1.13	1	2	0	0	100%	0.952
7JR8_GSH_B_202	100%	32%	0.044	0.996	1.49	1.2	2	1	0	0	100%	1
8AGQ_GSH_A_301	100%	52%	0.046	0.99	0.91	0.96	-	-	0	0	100%	1
4MF6_GSH_A_301	99%	52%	0.051	0.99	1.16	0.72	2	-	0	0	100%	1
3C8E_GSH_B_289	99%	10%	0.051	0.983	2.53	1.77	3	6	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.